Cargando…
Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
BACKGROUND: The aim of this study was to investigate the potential of cell-free DNA (cfDNA) as a disease biomarker in oesophageal squamous cell carcinoma (ESCC) that can be used for treatment response evaluation and early detection of tumour recurrence. METHODS: Matched tumour tissue, pre- and post-...
Autores principales: | Meng, Pei, Wei, Jiacong, Geng, Yiqun, Chen, Shaobin, Terpstra, Miente Martijn, Huang, Qiongyi, Zhang, Qian, Su, Zuoqing, Yu, Wanchun, Su, Min, Kok, Klaas, van den Berg, Anke, Gu, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701116/ https://www.ncbi.nlm.nih.gov/pubmed/31429737 http://dx.doi.org/10.1186/s12885-019-6025-2 |
Ejemplares similares
-
Mutations in EMT-Related Genes in ALK Positive Crizotinib Resistant Non-Small Cell Lung Cancers
por: Wei, Jiacong, et al.
Publicado: (2018) -
CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2022) -
The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth
por: Niu, Fubiao, et al.
Publicado: (2020) -
MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth
por: Niu, Fubiao, et al.
Publicado: (2020) -
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC
por: Wei, Jiacong, et al.
Publicado: (2021)